You are here: Welcome » COVID-19 Vaccines » Adverse Events Following COVID-19 Vaccination » COVID-19 Vaccine Associated Myocarditis

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
covid-19_vaccines:adverse_events:myocarditis [2022/01/27 18:14]
brian [Research] 		covid-19_vaccines:adverse_events:myocarditis [2022/07/15 06:21] (current)
liam
Line 1: Line 1:
 ====== COVID-19 Vaccine Associated Myocarditis ====== ====== COVID-19 Vaccine Associated Myocarditis ======
 +
 During the experimental [[:COVID-19 vaccines]] campaign, many vaccine recipients have suffered vaccine-associated [[:myocarditis]]. There is a debate over the nature of the damage caused in these cases of myocarditis as well as the relative risk of myocarditis associated with [[:SARS-CoV-2]] infection or [[:COVID-19]] cases. During the experimental [[:COVID-19 vaccines]] campaign, many vaccine recipients have suffered vaccine-associated [[:myocarditis]]. There is a debate over the nature of the damage caused in these cases of myocarditis as well as the relative risk of myocarditis associated with [[:SARS-CoV-2]] infection or [[:COVID-19]] cases.
  
Line 7: Line 8:
  
 ===== Research ===== ===== Research =====
 +
 Increased occurrence of myocarditis, pericarditis and myopericarditis has been associated with Covid-19 inoculations,((https://www.nature.com/articles/s41591-021-01630-0)) along with Covid-19 infection.  Increased occurrence of myocarditis, pericarditis and myopericarditis has been associated with Covid-19 inoculations,((https://www.nature.com/articles/s41591-021-01630-0)) along with Covid-19 infection. 
  
 {{ :myocarditis_vaers.jpg?600 |}} {{ :myocarditis_vaers.jpg?600 |}}
- 
  
 ^             Incidence of Myocarditis Following the Second Dose of a Covid-19 mRNA Vaccine               ^^^^^^^^^  ^             Incidence of Myocarditis Following the Second Dose of a Covid-19 mRNA Vaccine               ^^^^^^^^^ 
Line 21: Line 22:
 | Mevorach, Israel((https://www.nejm.org/doi/full/10.1056/NEJMoa2109730)) |  -  |   -  |  -  |   1 / 6637  | | Mevorach, Israel((https://www.nejm.org/doi/full/10.1056/NEJMoa2109730)) |  -  |   -  |  -  |   1 / 6637  |
  
 +A research letter published by JAMA claimed that rates of myocarditis and pericarditis increased less than 100% post-vaccination.((August 4, 2021 | George A. Diaz et al | [[:JAMA]] | Myocarditis and Pericarditis After Vaccination for COVID-19 | [[https://jamanetwork.com/journals/jama/fullarticle/2782900|doi:10.1001/jama.2021.13443]]))
  
  
Line 35: Line 36:
 The CDC continued to recommend use of these vaccinations while urging doctors to follow a list of clinical guidelines and to make VAERS reports as needed. ((https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html)) The CDC continued to recommend use of these vaccinations while urging doctors to follow a list of clinical guidelines and to make VAERS reports as needed. ((https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html))
  
-In the December 31, 2020 MMWR the CDC released information related to COVID-19 vaccine safety in children aged 5–11 years, covering the November 3–December 19, 2021 period of slightly over a five weeks.  The information was drawn from VEARS and VSAFE and was restricted to those who received Pfizer-BioNTech COVID-19 vaccine. ((https://www.cdc.gov/mmwr/volumes/70/wr/mm705152a1.htm))+In the December 31, 2021 MMWR the CDC released information related to COVID-19 vaccine safety in children aged 5–11 years, covering the November 3–December 19, 2021 period of slightly over a five weeks.  The information was drawn from VEARS and VSAFE and was restricted to those who received Pfizer-BioNTech COVID-19 vaccine. ((https://www.cdc.gov/mmwr/volumes/70/wr/mm705152a1.htm))
  
 ==== Small Hong Kong Studies ==== ==== Small Hong Kong Studies ====
Line 540: Line 541:
  
 [[https://www.nejm.org/doi/full/10.1056/NEJMc2116999?query=featured_home|Myocarditis after BNT162b2 Vaccination in Israeli Adolescents]] [[https://www.nejm.org/doi/full/10.1056/NEJMc2116999?query=featured_home|Myocarditis after BNT162b2 Vaccination in Israeli Adolescents]]
 +
 +[[https://pubmed.ncbi.nlm.nih.gov/35404496/|Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods]]
  
 ===== Link dump ===== ===== Link dump =====
Back to top